Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant

Christopher E Dandoy; Soyoung Kim; Min Chen; Kwang Woo Ahn; Monica I Ardura; Valerie Brown; Saurabh Chhabra; Miguel Angel Diaz; Christopher Dvorak; Nosha Farhadfar; Aron Flagg; Siddartha Ganguly; Gregory A Hale; Shahrukh K Hashmi; Peiman Hematti; Rodrigo Martino; Taiga Nishihori; Roomi Nusrat; Richard F Olsson; Seth J Rotz; Anthony D Sung; Miguel-Angel Perales; Caroline A Lindemans; Krishna V Komanduri; Marcie L Riches

doi:10.1001/jamanetworkopen.2019.18668

Back

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant

Journal article

Open access

Peer reviewed

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant

Christopher E Dandoy, Soyoung Kim, Min Chen, Kwang Woo Ahn, Monica I Ardura, Valerie Brown, Saurabh Chhabra, Miguel Angel Diaz, Christopher Dvorak, Nosha Farhadfar, …

JAMA network open, Vol.3(1), pp.e1918668-e1918668

2020-01-03

DOI: https://doi.org/10.1001/jamanetworkopen.2019.18668

PMCID: PMC6991246

PMID: 31913492

Abstract

Oncology

Online Only

Research

Original Investigation

This cohort study examines the incidence, timing, risk factors, and outcomes of patients who develop mucosal barrier injury–laboratory confirmed bloodstream infection (MBI-LCBI) in the first 100 days after hematopoietic stem cell transplant (HSCT).

Files and links (1)

url

https://doi.org/10.1001/jamanetworkopen.2019.18668View

Published (Version of record) Open

Metrics

6 Record Views

35 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.380 GvHD
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
Creators: Christopher E Dandoy - Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
Soyoung Kim - Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee
Min Chen - Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee
Kwang Woo Ahn - Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee
Monica I Ardura - Division of Infectious Disease, Department of Pediatrics, Nationwide Children’s Hospital, Columbus, Ohio
Valerie Brown - Division of Pediatric Oncology/Hematology, Department of Pediatrics, Penn State Hershey Children’s Hospital and College of Medicine, Hershey, Pennsylvania
Saurabh Chhabra - Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee
Miguel Angel Diaz - Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain
Christopher Dvorak - Divsion of Pediatric Allergy, Immunology & Bone Marrow Transplantation, Benioff Children’s Hospital, University of California, San Francisco
Nosha Farhadfar - Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville
Aron Flagg - Division of Pediatric Hematology-Oncology, Department of Pediatrics, Yale New Haven Hospital, New Haven, Connecticut
Siddartha Ganguly - Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City
Gregory A Hale - Department of Hematology/Oncology, Johns Hopkins All Children’s Hospital, St Petersburg, Florida
Shahrukh K Hashmi - Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
Peiman Hematti - Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin, Madison
Rodrigo Martino - Division of Clinical Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
Taiga Nishihori - Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Roomi Nusrat - Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
Richard F Olsson - Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
Seth J Rotz - Department of Pediatric Hematology, Oncology and Blood and Marrow Transplantation, Cleveland Clinic Children’s Hospital, Cleveland, Ohio
Anthony D Sung - Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina
Miguel-Angel Perales - Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Caroline A Lindemans - Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht University, Netherlands
Krishna V Komanduri - Department of Medicine, University of Miami, Miami, Florida
Marcie L Riches - Division of Hematology/Oncology, The University of North Carolina at Chapel Hill
Publication Details: JAMA network open, Vol.3(1), pp.e1918668-e1918668
Publisher: American Medical Association
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 31913492
PMCID: PMC6991246
Record Identifier: 991031578882302976